Stack · Cognition & Mood
Cognitive / Nootropic Stack (Semax + Selank + Dihexa)
Also searched as: cognitive stack, russian nootropic stack, calm focus stack, semax + selank, semax selank dihexa
A "brain peptide" combo marketed for focus, calm and memory: Semax for drive, Selank for anxiety, and Dihexa for synapse-building. Semax and Selank are Grade C (Russian-registered drugs with some human data); Dihexa is Grade D, with no human trials at all.
The verdict
Mixed evidence: the weakest link is Grade D — animal data only.
Stacking peptides doesn't combine their evidence — it combines their unknowns. A stack is only as proven as its members.
01 — What is it?
This isn't one product, it's a DIY combination of three peptides aimed at the brain. Semax (a synthetic fragment of ACTH) and Selank (a synthetic analogue of the immune peptide tuftsin) were both developed in Russia in the 1980s-90s and are registered medicines there, usually as nasal sprays. Dihexa is a newer, lab-made analogue of angiotensin IV from Washington State University research. The trio is a biohacker/seller construction, not a clinically studied protocol: the idea is that each one covers a different angle — Semax for cognition, Selank for calm, Dihexa for wiring new connections.
02 — Why it's hyped
The sales story divides the labour neatly. Semax is pitched as the pro-cognitive, "Miracle-Gro for the brain" peptide that raises BDNF and sharpens focus and memory. Selank is marketed as anti-anxiety without the sedation or dependence of benzodiazepines — the "calm" half of "calm focus". Dihexa gets billed as a synapse-builder, often with the claim that it's many orders of magnitude more potent than BDNF at growing new connections. Put together, vendors and clinics sell it as a complete "focused calm" package: drive plus mood plus rewiring.
03 — The honest take
Look at the grades before you look at the marketing. Semax and Selank are Grade C: they're real registered drugs in Russia with some human use behind them, but the Western evidence base is thin and the glossy "BDNF badass" claims run well ahead of what's actually been shown in good trials. Dihexa is the weak link — Grade D, with published evidence that is entirely preclinical. There are no completed human clinical trials on Dihexa itself; the "more potent than BDNF" line comes from cell cultures and rats, and one of the headline papers behind it has since been retracted. Stacking a couple of lightly-evidenced peptides with one that has no human data doesn't give you a guaranteed cognitive edge — it's an experiment you're running on yourself. And the people telling you it's "synergistic" are usually the ones selling the vials.
04 — What's actually in it
Cognition & Mood
Semax
A Russian brain peptide, prescribed there for strokes and concentration problems, that raises brain growth factors in animals but has almost no independent Western trial evidence.
Grade C · Some human data, far from settled.
Read entryCognition & Mood
Selank
A nasal-spray anxiety peptide developed and prescribed in Russia, with promising but mostly Russian small-scale human evidence and no licence in the UK.
Grade C · Some human data, far from settled.
Read entryCognition & Mood
Dihexa
An experimental memory-drug candidate derived from a blood-pressure hormone fragment that showed dramatic effects in rats but has never been tested in humans, and whose foundational study was retracted for falsified data.
Grade D · No meaningful human evidence yet.
Read entry05 — Is it legal in the UK?
None of the three is a licensed medicine in the UK. Semax and Selank are approved only in Russia (and a few neighbouring countries) and have never been through the MHRA or EMA; Dihexa has no approval anywhere. In the UK all three are sold as unlicensed "research chemicals", meaning no regulator has checked what's actually in the bottle, the purity, or the dose.
Last reviewed: 2026-06